| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 91.94B | 88.71B | 82.30B | 77.92B | 64.36B | 60.85B |
| Gross Profit | 51.30B | 48.36B | 46.63B | 42.18B | 32.96B | 29.58B |
| EBITDA | 7.22B | 7.03B | 5.55B | 3.29B | -1.37B | -7.29B |
| Net Income | 3.70B | 3.52B | 4.19B | 1.67B | -1.84B | -11.56B |
Balance Sheet | ||||||
| Total Assets | 70.47B | 71.49B | 64.23B | 57.05B | 52.22B | 44.89B |
| Cash, Cash Equivalents and Short-Term Investments | 38.78B | 46.13B | 40.64B | 35.71B | 30.83B | 20.40B |
| Total Debt | 23.78B | 29.08B | 26.76B | 24.68B | 25.02B | 26.60B |
| Total Liabilities | 41.11B | 44.35B | 42.06B | 39.24B | 37.59B | 41.49B |
| Stockholders Equity | 29.02B | 26.80B | 21.89B | 17.68B | 14.47B | 3.24B |
Cash Flow | ||||||
| Free Cash Flow | 3.95B | 5.52B | 2.80B | 5.10B | -692.00M | -6.85B |
| Operating Cash Flow | 6.50B | 6.89B | 4.74B | 6.68B | 1.02B | -4.32B |
| Investing Cash Flow | -3.40B | -6.56B | -3.06B | -4.99B | -15.37B | -3.41B |
| Financing Cash Flow | -1.06B | -13.00M | 59.00M | -1.54B | 10.10B | 11.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥134.20B | 14.74 | ― | 2.09% | 5.78% | 10.26% | |
66 Neutral | ¥185.28B | 27.13 | ― | 1.65% | 9.59% | 8.08% | |
65 Neutral | ¥41.36B | 3.96 | ― | 1.04% | 5.47% | 61.89% | |
63 Neutral | ¥750.98B | 45.71 | 9.53% | 0.55% | 15.58% | 60.90% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥217.02B | 72.52 | ― | 0.69% | 10.75% | -14.28% | |
53 Neutral | ¥383.63B | 34.66 | ― | 0.24% | 9.19% | 43.90% |